THE NICKLES GROUP, LLC for UCB, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act, and issues related to value-based payment arrangements. Issues related to Medicaid Drug Rebate Program. H.R. 5397, Joe Fiandra Access to Home Infusion Act of 2023. Issues concerning cybersecurity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
Monitored implementation of P.L.117-169, the Inflation Reduction Act, as it relates to corporate and international taxes. Issues related to the Orphan Drug Tax Credit. H.R. 7024, Tax Relief for American Families and Workers Act of 2024, as it relates to the R&D tax credit. Monitored H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals. Issues related to the 2025 expiration of the Tax Cut and Jobs Act provisions impacting corporations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
S. 652 / H.R. 2630, Safe Step Act and issues related to medication step therapy. Issues related to pharmacy benefit management. S.1375 / H.R. 830, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.